High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease.
High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease.
复制标题
DOI:
10.1016/j.jinf.2009.05.009
复制
发表时间:
2009-08
期刊:
影响因子:
--
通讯作者:
Poovorawan Y
中科院分区:
文献类型:
--
作者:
Linsuwanon P;Payungporn S;Samransamruajkit R;Posuwan N;Makkoch J;Theanboonlers A;Poovorawan Y
To determine the prevalence of human rhinoviruses (HRV) infections in children with lower respiratory disease in Thailand and monitor the association between species of HRV and clinical presentation in hospitalized paediatric patients. Two hundred and eighty-nine nasopharyngeal (NP) suction specimens were collected from hospitalized paediatric patients admitted to King Chulalongkorn Memorial Hospital, Thailand during February 2006–2007. Nucleic acids were extracted from each sample with subsequent amplification of VP4/2 by semi-nested RT-PCR for HRV detection. Other viral respiratory pathogens were also detected by PCR, RT-PCR or real time PCR. Nucleotide sequences of the VP4 region were used for genotyping and phylogenetic tree construction. In total, 87 of 289 specimens were positive for HRV indicating an annual prevalence of 30%. Wheezing or asthma exacerbation was the most common clinical presentation observed in infected patients. Sequence analysis and phylogenetic tree showed that 29 (33%) and 8 (9%) specimens belonged to HRV-A and HRV-B, respectively. Most of the HRV positive samples were HRV-C (58%). Moreover, species C was predominantly found in the paediatric population of Thailand in raining season (p < 0.05). The frequency of co-infection of HRV-C with other respiratory viral pathogens was approximately 40%. HRV-C represents the predominant species and is one of the etiologic agents in acute lower respiratory tract infection, causes of wheezing and asthma exacerbation in infants and young children in Thailand.
登录
查看更多内容
DOI:
10.1016/j.jaci.2008.10.007
发表时间:
2009-01
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Miller EK;Edwards KM;Weinberg GA;Iwane MK;Griffin MR;Hall CB;Zhu Y;Szilagyi PG;Morin LL;Heil LH;Lu X;Williams JV;New Vaccine Surveillance Network
通讯作者:
New Vaccine Surveillance Network
影响因子:
28.2
作者:
Samransamruajkit, R;Thanasugarn, W;Poovorawan, Y
通讯作者:
Poovorawan, Y
影响因子:
4.4
作者:
Chantzi, F. M.;Papadopoulos, N. G.;Kafetzis, D. A.
通讯作者:
Kafetzis, D. A.
影响因子:
11.8
作者:
Khetsuriani N;Lu X;Teague WG;Kazerouni N;Anderson LJ;Erdman DD
通讯作者:
Erdman DD
影响因子:
12.7
作者:
De Silva, D;Dagher, H;Bardin, PG
通讯作者:
Bardin, PG